Biotechnology firm Fractyl Health is implementing significant workforce reductions, impacting nearly half of its employees. This strategic decision involves discontinuing its gene therapy program to concentrate on a single product. The company aims to streamline operations and advance its weight maintenance treatment, Revita, toward market approval. These changes are expected to be finalized by next month. Co-founder Jay Caplan will also retire from his executive role.
Burlington, Massachusetts
https://www.masslive.com/business/2026/10/mass-biotech-company-to-lay-off-almost-half-its-staff.html